Retrospective Evaluation of the Accuracy of Roche AccuChek Inform and Nova StatStrip Glucose Meters when Used on Critically Ill Patients
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: More stringent accuracy guidelines for hospital-use glucose meters have recently been published, but it remains unclear whether glucose meters can meet these accuracy guidelines when measurement is performed on critically ill patients with fresh whole blood samples. MATERIALS AND METHODS: We performed a retrospective evaluation of a conventional (Roche Diagnostics [Indianapolis, IN] AccuChek® Inform) and a newer-generation (Nova Biomedical [Waltham, MA] StatStrip®) glucose system by comparing paired (drawn within 5 min of each other) whole blood glucose meter and laboratory serum glucose values obtained from intensive care unit (ICU) patients. We also performed a prospective evaluation of the accuracy of the Nova StatStrip. RESULTS: The median (interquartile range) bias between Roche AccuChek Inform and serum laboratory glucose measurements was 11 (6-18) mg/dL, compared with a median bias between the Nova StatStrip and serum glucose measurements of 1 (-5 to 5) mg/dL. StatStrip met International Organization for Standardization 15197 and Clinical and Laboratory Standards Institute (CLSI) POCT12-A3 accuracy guidelines using both retrospective and prospective datasets. CONCLUSIONS: The newer-generation (StatStrip) glucose meter met more stringent CLSI POCT12-A3 accuracy criteria because of reduced bias compared with the previous-generation device. Reduced glucose meter bias led to fewer insulin dosing discrepancies when the insulin dose determined from serum glucose was compared with that determined from the glucose meter value using the institutional glycemic control protocol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight glucose control in the intensive care unit: Are glucose meters up to the task?
Scott, M. G., Bruns, D. E., Boyd, J. C., & Sacks, D. B. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.117291 · Cited by 162
Glucose meter performance criteria for tight glycemic control estimated by simulation modeling
Karon, B. S., Boyd, J. C., & Klee, G. G. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.145367 · Cited by 94
Self-citationAnalytic evaluation of a new glucose meter system in 15 different critical care settings
Mitsios, J. V., Ashby, L. A., Haverstick, D. M., Bruns, D. E., & Scott, M. G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700518 · Cited by 30
Cited by
Galindo, R. J., Migdal, A. L., Davis, G. M., Urrutia, M. A., Albury, B., Zambrano, C., Vellanki, P., Pasquel, F. J., Fayfman, M., Peng, L., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2073 · Cited by 181
“By using glucose meters with validated accuracy in our study (29), we provide good correlation estimates.”
Zhang, R., Isakow, W., Kollef, M. H., & Scott, M. G. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002572 · Cited by 25
Karon, B. S., Meeusen, J. W., & Bryant, S. C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815602099 · Cited by 16
“Median (interquartile range) bias for GM1 whole blood glucose was 11 (6 to 18) mg/dL, compared to 1 (–5 to 5) mg/dL for GM2.(8) The range of laboratory serum glucose values in the GM1 data set was 32-411 mg/ dL, with 32 serum values in the hypoglycemic range (glucose < 70 mg/dL) and 94 serum glucose values in the hype…”
BackgroundResultInfluentialSelf-citation
Metadata
- Authors
- Karon, B. S., Blanshan, C. T., Deobald, G. R., & Wockenfus, A. M.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2014-12
- Volume
- 16
- Issue
- 12
- Pages
- 828-832
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2132346315
- Cited by
- 31
- References
- 3
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.